ORIGINAL_ARTICLE
Patient Mobility in the Global Marketplace: A Multidisciplinary Perspective
There is a growing global market in healthcare and patients. And while there is a small body of evidence emerging around this phenomenon commonly known as medical tourism there remain significant unanswered policy and research questions which need to be addressed. We outline some of the key issues set against the six key disciplinary preoccupations of the journal: epidemiology, health economics, health policy ethics, politics of health, health management, and health policy.
https://www.ijhpm.com/article_2844_0e19d41d8904ab54295fa0d11545f353.pdf
2014-05-01
155
157
10.15171/ijhpm.2014.47
Medical Tourism
Patient Mobility
Cross-Border Care
International Patients
Private Healthcare
Neil
Lunt
neil.lunt@york.ac.uk
1
Department of Social Policy and Social Work, University of York, Heslington, York, UK
LEAD_AUTHOR
Russell
Mannion
r.mannion@bham.ac.uk
2
Health Services Management Center, University of Birmingham, Birmingham, UK
AUTHOR
Kronfol NM. Delivery of health services in Arab countries: a review. East Mediterr Health J 2012; 18: 1229–38.
1
Glinos IA, Baeten R, Helble M, Maarse H. A typology of cross-border patient mobility. Health Place 2010; 16: 1145–55. doi: 10.1016/j.healthplace.2010.08.001
2
Carrera P, Lunt N. A European perspective on medical tourism: the need for a knowledge base. Int J Health Serv 2010; 40: 469–84. doi: 10.2190/hs.40.3.e
3
Lunt N, Smith R, Exworthy M, Green ST, Horsfall D, Mannion R. Medical Tourism: Treatments, Markets and Health System Implications: A scoping review [internet]. Directorate for Employment, Labour and Social Affairs. OECD: Paris, 2011. Available from: http://www.oecd.org/els/health-systems/48723982.pdf
4
Connell J. Contemporary medical tourism: Conceptualisation, culture and commodification. Tourism Management 2013; 34: 1–13. doi: 10.1016/j.tourman.2012.05.009
5
Ormond ME. Neoliberal governance and International medical travel in Malaysia. Abingdon: Routledge; 2013. doi: 10.4324/9780203077566
6
Keckley PH, Underwood HR. Medical Tourism: Consumers in Search of Value. Washington: Deloitte Center for Health Solutions; 2008.
7
Ehrbeck T, Guevara C, Mango PD. Mapping the Market for Medical Travel. The McKinsey Quarterly [internet]. 2008. Available: https://www.mckinseyquarterly.com/Mapping_the_market_for_travel_2134
8
McClean K. Medical Tourism: Or, for the politically correct... Cross Border Health Care. Presentation slides. Saskatchewan: University of Saskatchewan; 2008.
9
MacReady N. Developing countries court medical tourists. Lancet 2007; 369: 1849–50. doi: 10.1016/s0140-6736(07)60833-2
10
Crone RK. Flat Medicine? Exploring Trends in the Globalization of Health Care. Acad Med 2008; 83: 117–21. doi: 10.1097/acm.0b013e318160965c
11
Crozier GKD, Baylis F. The ethical physician encounters international medical travel. J Med Ethics 2010; 36: 297–301. doi: 10.1136/jme.2009.032789
12
Lunt N, Smith RD, Mannion R, Green ST, Exworthy M, Hanefeld, J, et al. Implications for the NHS of inward and outward medical tourism: a policy and economic analysis using literature review and mixed-methods approaches. Health Serv Deliv Res 2014; 2. doi: 10.3310/hsdr02020
13
Lunt N, Hanefeld J, Smith RD, Exworthy M, Horsfall D, Mannion R. Market size, market share and market strategy: three myths of medical tourism. Policy Polit 2013; forthcoming.
14
Alleman BW, Luger T, Reisinger HS, Martin R, Horowitz MD, Cram P. Medical Tourism Services Available to Residents of the United States. J Gen Intern Med 2011; 26: 492–7. doi: 10.1007/s11606-010-1582-8
15
Cortez N. Patients without borders: the emerging global market for patients and the evolution of modern health care. Indiana Law J 2008; 83: 71–131.
16
Rouchi AH, Mahdavi-Mazdeh M, Zamyadi M. Compensated living kidney donation in Iran: donor’s attitude and short-term follow-up. Iran Kidney Dis 2009; 3: 34–9.
17
Whittaker A. Challenges of medical travel to global regulation: A case study of reproductive travel in Asia. Glob Soc Policy 2010; 10: 396–415. doi: 10.1177/1468018110379981
18
Pellegrino ED. The commodification of medical and health care: the moral consequences of a paradigm shift from a professional to a market ethic. J Med Philos 1999; 24: 243–66. doi: 10.1076/jmep.24.3.243.2523
19
Smith RD, Martinez-Alvarez M, Chanda R. Medical tourism: a review of the literature and analysis of a role for bi-lateral trade. Health Policy 2011; 103: 276–82. doi: 10.1016/j.healthpol.2011.06.009
20
Cameron K, Crooks V Chouinard V Snyder J, Johnston R, Casey V. Motivation, justification, normalization: Talk strategies used by Canadian medical tourists regarding their choices to go abroad for hip and knee surgeries. Soc Sci Med 2014; 106: 93–100. doi: 10.1016/j.socscimed.2014.01.047
21
ORIGINAL_ARTICLE
Exploring the Dimensions of Doctor-Patient Relationship in Clinical Practice in Hospital Settings
The Doctor-Patient Relationship (DPR) is a complex concept in the medical sociology in which patients voluntarily approach a doctor and thus become a part of a contract in which they tends to abide with the doctor’s guidance. Globally, the DPR has changed drastically over the years owing to the commercialization and privatization of the health sector. Furthermore, the dynamics of the DPR has shown a significant change because of the formulation of consumer protection acts; clauses for professional misconduct and criminal negligence; establishment of patient forums and organizations; massive expansion of the mass media sector leading to increase in health awareness among people; and changes in the status of the doctors. Realizing the importance of DPR in the final outcome and quality of life of the patient, multiple measures have been suggested to make a correct diagnosis and enhance healing. To conclude, good DPR is the crucial determinant for a better clinical outcome and satisfaction with the patients, irrespective of the socio-cultural determinants.
https://www.ijhpm.com/article_2835_14f19dbe5229b49b695d3641a9e14881.pdf
2014-05-01
159
160
10.15171/ijhpm.2014.40
Doctor
Doctor-Patient Relationship (DPR)
Communication
Hospital
Saurabh
Shrivastava
drshrishri2008@gmail.com
1
Department of Community Medicine, Shri Sathya Sai Medical College & Research Institute, Kancheepuram, India
LEAD_AUTHOR
Prateek
Shrivastava
prateekbobhate@gmail.com
2
Department of Community Medicine, Shri Sathya Sai Medical College & Research Institute, Kancheepuram, India
AUTHOR
Jegadeesh
Ramasamy
tbcaremumbai4@gmail.com
3
Department of Community Medicine, Shri Sathya Sai Medical College & Research Institute, Kancheepuram, India
AUTHOR
1. Park K. Medicine and social sciences. In: Park K, editor. Textbook of Preventive and Social Medicine. 20th ed. Jabalpur: Banarsidas Bhanot; 2009. p. 604-5.
1
2. Lejoyeux M. The doctor-patient relationship: new psychological models. Bull Acad Natl Med 2011; 195: 1477–88.
2
3. Emanuel EJ, Dubler NN. Preserving the physician-patient relationship in the era of managed care. JAMA 1995; 273: 323–9. doi: 10.1001/jama.1995.03520280069043
3
4. Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy Press; 2001. doi: 10.1056/NEJM200108303450917
4
5. Mendoza MD, Smith SG, Eder MM, Hickner J. The seventh element of quality: the doctor-patient relationship. Fam Med 2011; 43: 83–9.
5
6. Banerjee A, Sanyal D. Dynamics of doctor-patient relationship: A cross-sectional study on concordance, trust, and patient enablement. J Family Community Med 2012; 19: 12–9. doi: 10.4103/2230-8229.94006
6
7. Werther JR. Focus on doctor-patient relationship the secret to practice success. Tenn Med 2010; 103: 9.
7
8. Hou X, Xiao L. An analysis of the changing doctor-patient relationship in China. J Int Bioethique 2012; 23: 83–9. doi: 10.3917/jib.232.0083
8
9. Dworzanski W, Dworzanska A, Burdan F. The essence of doctor-patient relationship in creating image of a medical institution. Pol Merkur Lekarski 2012; 32: 38–40.
9
10. Siebzehner MI, Balik C, Matalon A. Doctor-patient relationship in the context of a changing society. Harefuah 2008; 147: 1010–5.
10
11. Oyer DJ. Playing politics with the doctor-patient relationship. N Engl J Med 2012; 366: 2326–7. doi: 10.1056/NEJMc1205009
11
12. Finset A. “I am worried, Doctor!” Emotions in the doctor-patient relationship. Patient Educ Couns 2012; 88: 359–63. doi: 10.1016/j.pec.2012.06.022
12
13. Weber AS, Verjee MA, Musson D, Iqbal NA, Mosleh TM, Zainel AA, et al. Patient opinion of the doctor-patient relationship in a public hospital in Qatar. Saudi Med J 2011; 32: 293–9.
13
14. Williams S, Weinman J, Dale J. Doctor-patient communication and patient satisfaction: a review. Fam Pract 1998; 15: 480–92. doi: 10.1093/fampra/15.5.480
14
15. Terpstra OT. On doctor-patient relationship and feedback interventions. Perspect Med Educ 2012; 1: 159-61. doi: 10.1007/s40037-012-0030-3
15
16. Snyder U. The doctor-patient relationship II: not listening. Medscape J Med 2008; 10: 294.
16
17. Jagosh J, Boudreau DJ, Steinert Y, Macdonald ME, Ingram L. The importance of physician listening from the patients’ perspective: enhancing diagnosis, healing, and the doctor-patient relationship. Patient Educ Couns 2011; 85: 369–74. doi: 10.1016/j.pec.2011.01.028
17
18. Pourette D. Chronic hepatitis B and HIV care: the key-role of the doctor-patient relationship. Sante Publique 2013; 25: 561–70.
18
19. Skirbekk H, Middelthon AL, Hjortdahl P, Finset A. Mandates of trust in the doctor-patient relationship. Qual Health Res 2011; 21: 1182–90. doi: 10.1177/1049732311405685
19
20. Kuzari D, Biderman A, Cwikel J. Attitudes of women with breast cancer regarding the doctor-patient relationship. Eur J Cancer Care (Engl) 2013; 22: 589–96. doi: 10.1111/ecc.12063
20
21. Guenter D, Gillett J, Cain R, Pawluch D, Travers R. What do people living with HIV/AIDS expect from their physicians? Professional expertise and the doctor-patient relationship. J Int Assoc Physicians AIDS Care (Chic) 2010; 9: 341–5. doi: 10.1177/1545109710370486
21
22. Schers H, Webster S, van den Hoogen H, Avery A, Grol R, van den Bosch W. Continuity of care in general practice: a survey of patients’ views. Br J Gen Pract 2002; 52: 459–62.
22
23. Frederiksen HB, Kragstrup J, Dehlholm-Lambertsen B. Attachment in the doctor-patient relationship in general practice: a qualitative study. Scand J Prim Health Care 2010; 28: 185–90. doi: 10.3109/02813432.2010.505447
23
24. Benedetti F. Placebo and the new physiology of the doctor-patient relationship. Physiol Rev 2013; 93: 1207–46. doi: 10.1152/physrev.00043.2012
24
25. Taylor HJ, Bond CS. What e-patients want from the doctor-patient relationship: content analysis of posts on discussion boards. J Med Internet Res 2012; 14: e155. doi: 10.2196/jmir.2068
25
26. Sabesan S, Allen D, Caldwell P, Loh PK, Mozer R, Komesaroff PA, et al. Practical aspects of telehealth: doctor-patient relationship and communication. Intern Med J 2014; 44: 101–3. doi: 10.1111/imj.12323
26
27. Lacey C, Huria T, Beckert L, Gilles M, Pitama S. The Hui Process: a framework to enhance the doctor-patient relationship with Maori. N Z Med J 2011; 124: 72–8.
27
28. Prokopetz JJ, Lehmann LS. Physicians as fundraisers: medical philanthropy and the doctor-patient relationship. PLoS Med 2014; 11: e1001600. doi: 10.1371/journal.pmed.1001600
28
29. Engestrom Y. From doctor-patient relationship to a collaborative one. Duodecim 2013; 129: 651–5.
29
30. Chana P. Patient empowerment: a new dimension in doctor-patient relationship. Rev Med Chil 2012; 140: 404–5.
30
31. Egnew TR, Wilson HJ. Faculty and medical students’ perceptions of teaching and learning about the doctor-patient relationship. Patient Educ Couns 2010; 79: 199–206. doi: 10.1016/j.pec.2009.08.012
31
32. Sommer J, Rieder A, Haller DM. Learning about family medicine and the doctor-patient relationship: student views. Rev Med Suisse 2011; 7: 1100–5.
32
ORIGINAL_ARTICLE
Limited Knowledge of Chronic Kidney Disease and Its Main Risk Factors among Iranian Community: An Appeal for Promoting National Public Health Education Programs
Background The aim of this survey was to explore the baseline knowledge of the Iranian community about Chronic Kidney Disease (CKD) definition and its two main risk factors, i.e. diabetes and hypertension. This study also introduced a model of public education program with the purpose of reducing the incidence of CKD in high-risk groups and thereby decreasing the economic burden of CKD in Iran. Methods This cross-sectional study was conducted on world kidney day 2013 in Isfahan, Iran. Self-administered anonymous questionnaires evaluating the knowledge of CKD and its risk factors were distributed among subjects who participated in a kidney disease awareness campaign. Chi-square test and logistic regression analysis were used to examine the differences in the level of knowledge across different socio-demographic groups. Results The questionnaires were completed by 748 respondents. The majority of these respondents believed that “pain in the flanks” and “difficulty in urination” was the early symptoms of CKD. Roughly, 10.4% knew that CKD could be asymptomatic in the initial stages. Only 12.7% knew diabetes and 14.4% knew hypertension was a CKD risk factor. The respondents who had a CKD risk factor (i.e. diabetes and/or hypertension) were significantly more likely than respondents without CKD risk factor to select “unmanaged diabetes” [Odds Ratio (OR)= 2.2, Confidence Interval (CI) (95%): 1.4–3.6] and “unmanaged hypertension” [OR= 1.9, CI(95%): 1.2–3.0] as “very likely to result in CKD”. No more than 34.6% of all respondents with diabetes and/or hypertension reported that their physician has ever spoken with them about their increased risk for developing CKD. Conclusion The knowledge of Iranian population about CKD and its risk factors is low. Future public health education programs should put efforts in educating Iranian community about the asymptomatic nature of CKD in its initial stages and highlighting the importance of regular renal care counseling. The high-risk individuals should receive tailored education and be encouraged to adopt lifestyle modifications to prevent or slow the progression of CKD.
https://www.ijhpm.com/article_2834_99440f9f3630c500deb75464c049b32e.pdf
2014-05-01
161
166
10.15171/ijhpm.2014.37
Chronic Kidney Disease (CKD)
Knowledge
Diabetes
Hypertension
Prevention
Iran
Peyman
Roomizadeh
roomizadeh@gmail.com
1
Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
LEAD_AUTHOR
Diana
Taheri
d_tahererir@hotmail.com
2
Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
AUTHOR
Amin
Abedini
amin69.med@gmail.com
3
Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
AUTHOR
Mojgan
Mortazavi
mmortazav3@hotmail.com
4
Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
AUTHOR
Mehrdad
Larry
laarryms@hotmail.com
5
Endocrinology and Diabetes Division, Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Bahareh
Mehdikhani
bm_mehdikhani@hotmail.com
6
Endocrinology and Diabetes Division, Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Seyed-Mojtaba
Mousavi
mousamoj@hotmail.com
7
Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
AUTHOR
Farid-Aldin
Hosseini
p_roomi4144@hotmail.com
8
Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
AUTHOR
Aidin
Parnia
p_roomi4144@yahoo.com
9
Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
AUTHOR
Manouchehr
Nakhjavani
nakhjavbanim@hotmail.com
10
Endocrinology and Diabetes Division, Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007; 72: 247–59. doi: 10.1038/sj.ki.5002343
1
Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006; 17: 2034–47.
2
Levey AS, Astor BC, Stevens LA, Coresh J. Chronic kidney disease, diabetes, and hypertension: what’s in a name? Kidney Int 2010; 78: 19–22. doi: 10.1038/ki.2010.115
3
Levey AS, Coresh J. Chronic kidney disease. Lancet 2012; 379: 165–80. doi: 10.1016/s0140-6736(11)60178-5
4
Plantinga LC, Tuot DS, Powe NR. Awareness of chronic kidney disease among patients and providers. Adv Chronic Kidney Dis 2010; 17: 225–36. doi: 10.1053/j.ackd.2010.03.002
5
Tohidi M, Hasheminia M, Mohebi R, Khalili D, Hosseinpanah F, Yazdani B, et al. Incidence of chronic kidney disease and its risk factors, results of over 10 year follow up in an Iranian cohort. PLoS One 2012; 7: e45304. doi: 10.1371/journal.pone.0045304
6
Nafar M, Mousavi SM, Mahdavi-Mazdeh M, Pour-Reza-Gholi F, Firoozan A, Einollahi B, et al. Burden of chronic kidney disease in Iran: a screening program is of essential need. Iran J Kidney Dis 2008; 2: 183–92.
7
Mahdavi-Mazdeh M. Why do we need chronic kidney disease screening and which way to go? Iran J Kidney Dis 2010; 4: 275–81.
8
Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med 2006; 354: 997–9. doi: 10.1056/nejmp058318
9
Chow WL, Joshi VD, Tin AS, van der Erf S, Lim JF, Swah TS, et al. Limited knowledge of chronic kidney disease among primary care patients--a cross-sectional survey. BMC Nephrol 2012; 13: 54. doi: 10.1186/1471-2369-13-54
10
Swartz MD, Robinson K, Davy T, Politoski G. The role of patients in the implementation of the National Kidney Foundation-Dialysis Outcomes Quality Initiative. Adv Ren Replace Ther 1999; 6: 52–8.
11
Lorig K, Ritter PL, Villa F, Piette JD. Spanish diabetes self-management with and without automated telephone reinforcement: two randomized trials. Diabetes Care 2008; 31: 408–14. doi: 10.2337/dc07-1313
12
Wright-Nunes JA, Luther JM, Ikizler TA, Cavanaugh KL. Patient knowledge of blood pressure target is associated with improved blood pressure control in chronic kidney disease. Patient Educ Couns 2012; 88: 184–8. doi: 10.1016/j.pec.2012.02.015
13
Hemmelgarn BR, Zhang J, Manns BJ, James MT, Quinn RR, Ravani P, et al. Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate. JAMA 2010; 303: 1151–8. doi: 10.1001/jama.2010.303
14
Events Map, World Kidney Day [internet]. [cited 2013 August 30]. Available from: http://www.worldkidneyday.org/events/map?id=913
15
Waterman AD, Browne T, Waterman BM, Gladstone EH, Hostetter T. Attitudes and behaviors of African Americans regarding early detection of kidney disease. Am J Kidney Dis 2008; 51: 554–62. doi: 10.1053/j.ajkd.2007.12.020
16
White SL, Polkinghorne KR, Cass A, Shaw J, Atkins RC, Chadban SJ. Limited knowledge of kidney disease in a survey of AusDiab study participants. Med J Aust 2008; 188: 204–8.
17
Boulware LE, Carson KA, Troll MU, Powe NR, Cooper LA. Perceived susceptibility to chronic kidney disease among high-risk patients seen in primary care practices. J Gen Intern Med 2009; 24: 1123–9. doi: 10.1007/s11606-009-1086-6
18
Tan AU, Hoffman B, Rosas SE. Patient perception of risk factors associated with chronic kidney disease morbidity and mortality. Ethn Dis 2010; 20: 106–10.
19
Ayotte BJ, Trivedi R, Bosworth HB. Racial differences in hypertension knowledge: effects of differential item functioning. Ethn Dis 2009; 19: 23–7.
20
Fezeu L, Fointama E, Ngufor G, Mbeh G, Mbanya JC. Diabetes awareness in general population in Cameroon. Diabetes Res Clin Pract 2010; 90: 312–8. doi: 10.1016/j.diabres.2010.06.029
21
Ohmit SE, Flack JM, Peters RM, Brown WW, Grimm R. Longitudinal Study of the National Kidney Foundation’s (NKF) Kidney Early Evaluation Program (KEEP). J Am Soc Nephrol 2003; 14: S117–21. doi: 10.1097/01.asn.0000070155.63971.b2
22
Vassalotti JA, Li S, Chen SC, Collins AJ. Screening populations at increased risk of CKD: the Kidney Early Evaluation Program (KEEP) and the public health problem. Am J Kidney Dis 2009; 53: S107–14. doi: 10.1053/j.ajkd.2008.07.049
23
Whaley-Connell AT, Vassalotti JA, Collins AJ, Chen SC, McCullough PA. National Kidney Foundation’s Kidney Early Evaluation Program (KEEP) annual data report 2011: executive summary. Am J Kidney Dis 2012; 59: S1–4. doi: 10.1053/j.ajkd.2011.11.018
24
Kurella Tamura M, Li S, Chen SC, Cavanaugh KL, Whaley-Connell AT, McCullough PA, et al. Educational programs improve the preparation for dialysis and survival of patients with chronic kidney disease. Kidney Int 2014; 85: 686–92. doi: 10.1038/ki.2013.369
25
ORIGINAL_ARTICLE
Strategic Collaborative Quality Management and Employee Job Satisfaction
Background This study aimed to examine Strategic Collaborative Quality Management (SCQM) impact on employee job satisfaction. Methods The study presents a case study over six years following the implementation of the SCQM programme in a public hospital. A validated questionnaire was used to measure employees’ job satisfaction. The impact of the intervention was measured by comparing the pre-intervention and post-intervention measures in the hospital. Results The hospital reported a significant improvement in some dimensions of job satisfaction like management and supervision, organisational policies, task requirement, and working conditions. Conclusion This paper provides detailed information on how a quality management model implementation affects employees. A well developed, well introduced and institutionalised quality management model can improve employees’ job satisfaction. However, the success of quality management needs top management commitment and stability.
https://www.ijhpm.com/article_2836_48a7d515be7af72a95b39763952c3a32.pdf
2014-05-01
167
174
10.15171/ijhpm.2014.38
Strategic Collaborative Quality Management
Employee Job Satisfaction
Hospital
Ali Mohammad
Mosadeghrad
mosadeghrad@gmail.com
1
Health Management and Economics Research Centre, School of Health Management and Information Sciences, Tehran University of Medical Sciences, Tehran, Iran
LEAD_AUTHOR
Boon OK, Arumugam V, Hwa TS. Does soft TQM predict employees’ attitudes? The TQM Magazine 2005; 17: 279–89. doi: 10.1108/09544780510594243
1
Forza C, Filippini R. TQM impact on quality conformance and customer satisfaction: A causal model. International Journal of Production Economics 1998; 55: 1–20. doi: 10.1016/s0925-5273(98)00007-3
2
Agus A. TQM as a focus for improving overall service performance and customer satisfaction: An empirical study on a public service sector in Malaysia. Total Quality Management 2002; 15: 615–28. doi: 10.1080/14783360410001680107
3
Martinez-Costa M, Jimenez-Jimenez D. Are companies that implement TQM better learning organizations? An empirical study. Total Quality Management 2008; 19: 1101–15. doi: 10.1080/14783360802323446
4
Rahman S. Total quality management practices and business outcome: evidence from small and medium enterprises in Western Australia. Total Quality Management 2001; 12: 201–10. doi: 10.1080/09544120120011424
5
Agus A, Abdullah M. Total quality management practices in manufacturing companies in Malaysia: An exploratory analysis. Total Quality Management & Business Excellence 2000; 11: 1041–51. doi: 10.1080/095441200440313
6
Hansson J, Eriksson H. The impact of TQM on financial performance. Measuring Business Excellence 2002; 6: 44–54. doi: 10.1108/13683040210451714
7
Joiner TA. Total quality management and performance: The role of organisation support and co-worker support. International Journal of Quality & Reliability Management 2007; 24: 617–27. doi: 10.1108/02656710710757808
8
Garvin D. Managing quality: The strategic and competitive edge. New York: Free Press; 1988.
9
Madu CN, Kuei C. Strategic Total Quality Management: Transformation process overview. Total Quality Management 1994; 5: 255–66. doi: 10.1080/09544129400000046
10
Kim KY, Chang DR. Global quality management: A research focus. Decision Sciences 1995; 26: 561–8. doi: 10.1111/j.1540-5915.1995.tb01440.x
11
Mosadeghrad AM. A theory of quality management. International Journal of Modelling in Operations Management 2012; 2: 89–118. doi: 10.1504/ijmom.2012.043962
12
Ennis K, Harrington D. Quality management in Irish health care. Int J Health Care Qual Assur 1999; 12: 232–43. doi: 10.1108/09526869910287305
13
Mosadeghrad AM. Obstacles to TQM success in health care systems. Int J Health Care Qual Assur 2013; 26: 147–73. doi: 10.1108/09526861311297352
14
Zabada CP, Rivers A, Munchus G. Obstacles to the application of total quality management in health care organisations. Total Quality Management 1998; 9: 57–66. doi: 10.1080/0954412989261
15
Mosadeghrad AM. Verification of a quality management theory: Using a Delphi study. Int J Health Policy Manag 2013; 1: 261–71. doi: 10.1080/0954412989261
16
Mosadeghrad AM. Implementing Strategic Collaborative Quality Management in Health Care Sector. International Journal of Strategic Change Management 2012; 4: 203–28.
17
Mohrman SA, Tenkasi RV, Lawler EE III, Ledford GG Jr. Total quality management: Practice and outcomes in the largest US firms. Employee Relations 1995; 17: 26–41. doi: 10.1108/01425459510086866
18
Lee LC, Yang KP, Chen TY. A quasi-experimental study on a quality circle program in a Taiwanese hospital. Int J Qual Health Care 2000; 12: 413–8. doi: 10.1093/intqhc/12.5.413
19
Alsughayir A. Does practicing total quality management affect employee job satisfaction in Saudi Arabian organizations? European Journal of Business and Management 2014; 6: 169–75.
20
Guimaraes T. TQM’s impact on employee attitudes. The TQM Magazine 1996; 8: 20. doi: 10.1108/09544789610107225
21
McAdam R, Bannister A. Business performance measurement and change management within a TQM framework’, International Journal of Operations and Production Management 2001; 21: 88–107. doi: 10.1108/01443570110358477
22
Boselie P, van der Wiele T. Employee perceptions of HRM and TQM, and the effects on satisfaction and intention to leave.Managing Service Quality 2002; 12: 165–73. doi: 10.1108/09604520210429231
23
Parker SK. Longitudinal effects of lean production on employee outcomes and the mediating role of work characteristics. J Appl Psychol 2003; 88: 620–34. doi: 10.1037/0021-9010.88.4.620
24
Landsbergis PA, Cahill J, Schnall P. The impact of lean production and related new systems of work organization on worker health. J Occup Health Psychol 1999; 4: 108–30. doi: 10.1037/1076-8998.4.2.108
25
Vidal M. Lean production, worker employment, and job satisfaction: A qualitative analysis and critique. Critical Sociology 2007; 33: 247–78. doi: 10.1163/156916307x168656
26
Mosadeghrad AM, Ferlie E, Rosenberg D. A study of relationship between job satisfaction, organisational commitment and turnover intention among hospital employees. Health Serv Manage Res 2008; 21: 211–27. doi: 10.1258/hsmr.2007.007015
27
Oakland JS. Total quality management: Text with cases. 3rd ed. Oxford: Butterworth- Heinemann; 2003.
28
Brown S, Lam S. A meta-analysis of relationships linking employee satisfaction to customer responses. Journal of Retailing 2008; 84: 243–55. doi: 10.1016/j.jretai.2008.06.001
29
Capelli P. A market driven approach to retaining talent. Harv Bus Rev 2000; 78: 103–11.
30
Akdere M. A multi-level examination of quality-focused human resource practices and firm performance: Evidence from the US healthcare industry. International Journal of Human Resource Management 2009; 20: 1945–64. doi: 10.1080/09585190903142399
31
Sila I. Examining the effects of contextual factors on TQM and performance through the lens of organisational theories: An empirical study. Journal of Operations Management 2007; 25: 83–109. doi: 10.1016/j.jom.2006.02.003
32
Karia N, Asaari MH. The effects of total quality management practices on employees’ work-related attitudes. The TQM Magazine 2006; 18: 30–43. doi: 10.1108/09544780610637677
33
Lagrosen Y, Backstrom I, Lagrosen S. Quality management and health: A double connection. International Journal of Quality & Reliability Management 2007; 24: 49–61. doi: 10.1108/02656710710720321
34
Woodward CA, Shannon HS, Cunningham C, McIntosh J, Lendrum B, Rosenbloom D, et al. The impact of re-engineering and other cost reduction strategies on the staff of a large teaching hospital: a longitudinal study. Med Care 1999; 37: 556–69. doi: 10.1097/00005650-199906000-00005
35
Mosadeghrad AM, Ferdosi M, Afshar H, Hosseini-Nejhad M. The impact of top management turnover on quality management implementation. Med Arh 2013; 67: 134–40. doi: 10.5455/medarh.2013.67.134-140
36
Taylor WA, Wright GH. The impact of senior managers’ commitment on the success of TQM programmes: An empirical study. Int J Manpow 2003; 24: 535–50. doi: 10.1108/01437720310491071
37
Rad AM, Yarmohammadian MH. A study of relationship between managers’ leadership style and employees’ job satisfaction. Int J Health Care Qual Assur Inc Leadersh Health Serv 2006; 19: xi-xxviii. doi: 10.1108/13660750610665008
38
Baidoun S. An empirical study of critical factors of TQM in Palestinian organizations. Logistics Information Management 2003; 16: 156–71. doi: 10.1108/09576050310467296
39
Wimalasir JS, Kouzmin A. A comparative Study of employee involvement initiatives in Hong Kong and the USA. Int J Manpow 2000; 21: 614–34. doi: 10.1108/01437720010379510
40
Hamidi Y, Eivazi Z. The Relationships Among Employees’ Job Stress, Job Satisfaction, and the Organizational Performance of Hamadan Urban Health Centers. Social Behavior and Personality: An international Journal 2010; 38: 963–8. doi: 10.2224/sbp.2010.38.7.963
41
Gallear D, Ghobadian A. An empirical investigation of the channels that facilitate a total quality culture. Total Quality Management 2004; 15: 1043–67. doi: 10.1080/1478336042000255497
42
Wilkinson A. Quality and the Human Factor. Total Quality Management 2004; 15: 1019–24. doi: 10.1080/1478336042000255415
43
Kassicieh SK, Yourstone SA. Training, performance evaluation, rewards, and TQM implementation success. Journal of Quality Management 1998; 3: 25–38. doi: 10.1016/s1084-8568(99)80102-3
44
ORIGINAL_ARTICLE
National Health Insurance Scheme: How Protected Are Households in Oyo State, Nigeria from Catastrophic Health Expenditure?
Background The major objective of the National Health Insurance Scheme (NHIS) in Nigeria is to protect families from the financial hardship of large medical bills. Catastrophic Health Expenditure (CHE) is rampart in Nigeria despite the take-off of the NHIS. This study aimed to determine if households enrolled in the NHIS were protected from having CHE. Methods The study took place among 714 households in urban communities of Oyo State. CHE was measured using a threshold of 40% of monthly non-food expenditure. Descriptive statistics were done, Principal Component Analysis was used to divide households into wealth quintiles. Chi-square test and binary logistic regression were done. Results The mean age of household respondent was 33.5 years. The median household income was 43,500 naira (290 US dollars) and the range was 7,000–680,000 naira (46.7–4,533 US dollars) in 2012. The overall median household healthcare cost was 890 naira (5.9 US dollars) and the range was 10-17,700 naira (0.1–118 US dollars) in 2012. In all, 67 (9.4%) households were enrolled in NHIS scheme. Healthcare services was utilized by 637 (82.9%) and CHE occurred in 42 (6.6%) households. CHE occurred in 14 (10.9%) of the households in the lowest quintile compared to 3 (2.5%) in the highest wealth quintile (P= 0.004). The odds of CHE among households in lowest wealth quintile is about 5 times. They had Crude OR (CI): 4.7 (1.3–16.8), P= 0.022. Non enrolled households were two times likely to have CHE, though not significant Conclusion Households in the lowest wealth quintiles were at higher risk of CHE. Universal coverage of health insurance in Nigeria should be fast-tracked to give the expected financial risk protection and decreased incidence of CHE.
https://www.ijhpm.com/article_2837_a1c2a72b48a82940a19afb06e2e8f6f6.pdf
2014-05-01
175
180
10.15171/ijhpm.2014.39
National Health Insurance Scheme (NHIS)
Catastrophic Health Expenditure (CHE)
Households
Wealth Quintiles
Cost
Healthcare Utilization
Olayinka
Ilesanmi
ileolasteve@yahoo.co.uk
1
Department of Community Health, Federal Medical Centre, Owo, Ondo State, Nigeria
LEAD_AUTHOR
Akindele
Adebiyi
adebiyi20012002@yahoo.com
2
Department of Community Health, Federal Medical Centre, Owo, Ondo State, Nigeria
AUTHOR
Akinola
Fatiregun
akinfati@yahoo.com
3
Department of Epidemiology and Medical Statistics, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria
AUTHOR
Water HR, Anderson GF, Mays J. Measuring financial protection in health in the United States. Health Policy 2004; 69: 339–49. doi:10.1016/j.healthpol.2004.01.003
1
Ranson MK. Reduction of catastrophic health care expenditures by a community-based health insurance scheme in Gujarat, India: current experiences and challenges. Bull World Health Organ 2002; 80: 613–21.
2
Wagstaff A. Poverty and health sector inequalities. Bull World Health Organ 2002; 80: 97–105.
3
Kawabata K, Xu K, Carrin G. Preventing impoverishment through protection against catastrophic health expenditure. Bull World Health Organ 2002; 80: 612.
4
Wagstaff A, Lindelowb M, Junc G, Lingc X, Jonchengc Q. Extending health insurance to the rural population: An impact evaluation of China’s new operative medical scheme. J Health Econ 2009; 28: 1–19.
5
Obikeze OO, Ige OK, Osungbade KO, Asuzu MC, Olumide AE. An overview of the National Health Insurance Scheme in Nigeria. Dokita 2010; 1: 15–21.
6
NHIS. National Health Insurance Scheme Handbook. Operational Guidelines on National Health Insurance Scheme. Federal Republic of Nigeria: Ministry of Health; 2006. doi: 10.4314/msjm.v3i1.10989
7
Soyibo A. National Health Accounts (NHA) of Nigeria. Federal Republic of Nigeria: Ministry of Health; 2009. doi: 10.4314/ajep.v14i1.44195
8
National Health Insurance Scheme (NHIS). Road map for the implementation of Community-based health insurance scheme in Nigeria. Consultation on Support to NHIS CBSHIS roll-out in Programme States. Abuja: PPRINN-MNCH/NHIS; 2011.
9
Nguyen HT, Rajkotia Y, Wang H. The financial protection effect of Ghana National Health Insurance Scheme: evidence from a study in two rural districts. Int J Equity Health 2011; 19: 4. doi: 10.1186/1475-9276-10-4
10
Obikeze E, Onwujekwe O, Uzochukwu B, Chukwuogo O, Uchegbu E, Soludo E, et al. Benefit incidence of national health insurance scheme in enugu state, Southeast Nigeria. African Journal Health Econ 2013; forthcoming.
11
Ilesanmi OS, Ige OK. Equity of care: A comparison of National Health Insurance Scheme enrolees and fee-paying patients at a private health facility in Ibadan, Nigeria. J Public Health Epidemiol 2013; 5: 51–5.
12
Akande TM, Ogunrinola EO. Health care financing among inpatients of a tertiary health facility in Ilorin, Nigeria. Niger J Clin Pract 2000; 2: 1–4.
13
Adinma B, Adinma E. Community based healthcare financing: An untapped option to a more effective healthcare funding in Nigeria. Niger Med J 2010; 51: 95–100.
14
Oyo State Health Facility Directory 2007. Ibadan: HMIS Department of Planning Research & Statistics Oyo State Ministry of Health; 2008.
15
Bender DR. A Refinement of the Concept of Household: Families, Co-residence, and Domestic Functions. Am Anthropol 1967; 69: 493–504. doi: 10.1525/aa.1967.69.5.02a00050
16
van Doorslaer E, O’Donnell O, Rannan-Eliya R, Somanathan A, Adhikari S, Garg C, et al. Effect of payments for health care on poverty estimates in 11 countries in Asia: an analysis of household survey data. Lancet 2006; 368: 1357–64. doi: 10.1016/s0140-6736(06)69560-3
17
O’Donnell O, van Doorslaer E, Wagstaff A, Lindelow M. Analyzing health equity using household survey data: A guide to techniques and their implementation. Washington, DC: The World Bank; 2008. doi: 10.1596/978-0-8213-6933-3
18
Onoka CA, Onwujekwe OE, Hanson K, Uzochukwu BS. Examining catastrophic health expenditures at variable thresholds using household consumption expenditure diaries. Trop Med Int Health 2011; 16: 1334–1. doi: 10.1111/j.1365-3156.2011.02836.x
19
NPC, ICF Macro. Nigeria Demographic and Health Survey 2008. Abuja: National Population Commission and ICF Macro; 2009.
20
Wagstaff A, Doorslaer E. Catastrophe and impoverishment in paying for health care: with applications to Vietnam 1993–1998. Health Econ 2003; 12: 921–33. doi: 10.1002/hec.776
21
Saksena P, Antunes AF, Xu K, Musango L, Carrin G. Mutual health insurance in Rwanda: evidence on access to care and financial risk protection. Health Policy 2011; 99: 203–9. doi: 10.1016/j.healthpol.2010.09.009
22
Onwujekwe O, Hanson K, Uzochukwu B. Examining Inequities in Incidence of Catastrophic Health Expenditures on Different Healthcare Services and Health Facilities in Nigeria. PLoS One 2012; 7: e40811. doi: 10.1371/journal.pone.0040811
23
Onwujekwe O, Okereke E, Onoka C, Uzochukwu B, Kirigia J, Petu A. Willingness to pay for community-based health insurance in Nigeria: do economic status and place of residence matter? Health Policy Plan 2009; 25: 155–61. doi: 10.1093/heapol/czp046
24
Ezeoke OP, Onwujekwe OE, Uzochukwu BS. Towards Universal Coverage: Examining Costs of Illness, Payment, and Coping Strategies to Different Population Groups in Southeast Nigeria. Am J Trop Med Hyg 2012; 86: 52–7. doi: 10.4269/ajtmh.2012.11-0090
25
Ekman B. Catastrophic health payments and health insurance: some counterintuitive evidence from low-income country. Health Policy 2007; 83: 304–13. doi: 10.1016/j.healthpol.2007.02.004
26
ORIGINAL_ARTICLE
Does Tuberculosis Have a Seasonal Pattern among Migrant Population Entering Iran?
Background There are few quantitative documents about the seasonal incidence of tuberculosis (TB) among immigrant populations. Concerning the significant role of recognizing seasonal changes of TB in improving the TB control program, this study determines the trend and seasonal temporal changes of TB among immigrants entering Iran. Methods In this longitudinal study, data from the Iranian TB register Program (from 2005 to 2011) was used. The aggregated number of monthly and seasonal TB cases was obtained by adding the daily counts. Data was analyzed by Chi-square, Independent T-test, ANOVA, and Poisson regression using Stata 11 and SPSS 20 software. Results Among 74,155 registered patients with TB, 14.3% (10,587) were non-Iranian who had immigrated to Iran from 29 different countries. The highest aggregated number of seasonal and monthly incidence of TB in immigrants was observed in spring (2824, P= 0.007) and in May (1037, P< 0.001). The number of non-Iranian patients with TB increased significantly over the years (β= 0.016, P= 0.001). Conclusion This study shows that immigrants constitute a significant portion of TB patients recorded in Iran and this trend is increasing. Also, the peak incidence of this disease is the second month of the spring.
https://www.ijhpm.com/article_2840_78407f40ceb377be090637c5fbf160b4.pdf
2014-05-01
181
185
10.15171/ijhpm.2014.43
Tuberculosis (TB)
Seasonality
Iran
Migrant
Mahmood
Moosazadeh
mmoosazadeh1351@gmail.com
1
Mazandaran University of Medical Sciences, Sari, Iran
AUTHOR
Narges
Khanjani
narges.khanjani@gmail.com
2
Neurology Research Center, Shafa Hospital, Kerman University of Medical Sciences, Kerman, Iran
AUTHOR
Abbas
Bahrampour
abahrampour@yahoo.com
3
Department of Biostatistics and Epidemiology, Faculty of Health, Kerman University of Medical Sciences, Kerman, Iran
AUTHOR
Mahshid
Nasehi
mnasehi@yahoo.com
4
Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran
LEAD_AUTHOR
Moosazadeh M, Khanjani N, Bahrampoor A. Seasonality and Temporal Variations of Tuberculosis in the North of Iran. Tanaffos 2013; 12: 35–41.
1
Ignatova A, Dubiley S, Stepanshina V, Shemyakin I. Predominance of multi-drug-resistant LAM and Beijing family strains among Mycobacterium tuberculosis isolates recovered from prison inmates in Tula Region, Russia. J Med Microbiol 2006; 55: 1413–8. doi: 10.1099/jmm.0.46575-0
2
Hassanzadeh J, Nasehi M, Rezaianzadeh A, Tabatabaee H, Rajaeifard A, Ghaderi E. Pattern of Reported Tuberculosis Cases in Iran 2009-2010. Iran J Public Health 2013; 42: 72–8.
3
Dye C, Watt CJ, Bleed D. Low access to a highly effective therapy: A challenge for international tuberculosis control. Bull World Health Organ 2002; 80: 437–44.
4
Corbett EL, Bandason T, Bun Cheung YB, Munyati S, Godfrey-Faussett P, Hayes R, et al. Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease. PLoS Med 2007; 4: e22. doi: 10.1371/journal.pmed.0040022
5
Moosazadeh M, Khanjani N. The Existing Problems in the Tuberculosis Control Program of Iran: A Qualitative Study. Journal of Qualitative Research in Health Sciences 2012; 1: 189–201.
6
Nasehi M, Moosazadeh M, Amiresmaeili M, Parsaee M, Nezammahalleh A. [The Epidemiology of Factors Associated with Screening and Treatment Outcomes of Patients with Smear Positive Pulmonary Tuberculosis: A Population-Based Study]. J Mazandaran Univ Med Sci 2012; 21 : 9–18.
7
Migliori GB, Espinal M, Danilova ID, Punga VV, Grzemska M, Raviglione MC. Frequency of recurrence among MDR-tB cases successfully treated with standardised short-course chemotherapy. Int J Tuberc Lung Dis 2002; 6: 858–64.
8
Arshad S, Bavan L, Gajari K, Paget SNJ, Baussano I. Active screening at entry for tuberculosis among new immigrants: a systematic review and meta-analysis. Eur Respir J 2010; 35: 1336–45. doi: 10.1183/09031936.00054709
9
Dasgupta K, Menzies D. Cost-effectiveness of tuberculosis control strategies among immigrants and refugees. Eur Respir J 2005; 25: 1107–16. doi: 10.1183/09031936.05.00074004
10
Cohen T, Murray M. Incident tuberculosis among recent US immigrants and exogenous reinfection. Emerg Infect Dis 2005; 11: 725. doi: 10.3201/eid1105.041107
11
Vos AM, Meima A, Verver S, Looman CW, Bos V, Borgdorff MW, et al. High incidence of pulmonary tuberculosis persists a decade after immigration, the Netherlands. Emerg Infect Dis 2004; 10: 736–9. doi: 10.3201/eid1004.030530
12
Lillebaek T, Andersen AB, Dirksen A, Smith E, Skovgaard LT, kok-Jensen A. Persistent high incidence of tuberculosis in immigrants in a low-incidence country. Emerg Infect Dis 2002; 8: 679. doi: 10.3201/eid0807.010482
13
Akhtar S, Mohammad HG. Nonlinear pattern of pulmonary tuberculosis among migrants at entry in Kuwait: 1997–2006. BMC Public Health 2008; 8: 264. doi: 10.1186/1471-2458-8-264
14
Douglas AS, Strachan DP, Maxwell JD. Seasonality of tuberculosis: The reverse of other respiratory diseases in the UK. Thorax 1996; 51: 944–6. doi: 10.1136/thx.51.9.944
15
Rios M, Garcia JM, Sanchez JA, Perez D. A statistical analysis of the seasonality in pulmonary tuberculosis. Eur J Epidemiol 2000; 16: 483–8.
16
Thorpe LE, Frieden TR, Laserson KF, Wells C, Khatri GR. Seasonality of tuberculosis in India: is it real and what does it tell us? Lancet 2004; 364: 1613–4. doi: 10.1016/s0140-6736(04)17316-9
17
Leung CC, Yew WW, Chan TYK, Tam CM, Chan CY, Chan CK, et al. Seasonal pattern of tuberculosis in Hong Kong. Int J Epidemiol 2005; 34: 924–30.
18
Nagayama N, Ohmori M. Seasonality in various forms of tuberculosis. Int J Tuberc Lung Dis 2006; 10: 1117–22.
19
Luqureo FJ, Sanchez-Padilla E, Simon-Soria F, Eiros JM, Golub JE. Trend and seasonality of tuberculosis in Spain, 1996-2004. Int J Tuberc Lung Dis 2008; 12: 221–4.
20
Schaaf HS, Nel ED, Beyers N, Gie RP, Scott F, Donald PR. A decade of experience with Mycobacterium tuberculosis culture from children: a seasonal influence on incidence of childhood tuberculosis. Tuber Lung Dis 1996; 77: 43–6. doi: 10.1016/s0962-8479(96)90074-x
21
Yamamoto S, Shimizu A, KUchimura K, Ohmori MMA. Seasonal variatin in the incidence of pulmonary tuberculosis among the eldery in the Kanto area and its metrological factors. JPN J Biometeor 2003; 40: 83–92
22
Liao CM, Hsieh NH, Huang TL, Cheng YH, Lin YJ, Chio CP, et al. Assessing trends and predictors of tuberculosis in Taiwan. BMC Public Health 2012; 12: 29. doi: 10.1186/1471-2458-12-29
23
Fares A. Seasonality of Tuberculosis. J Glob Infect Dis 2011; 3: 46–55. doi: 10.4103/0974-777x.77296
24
Willis MD, Winston CA, Heilig CM, Cain KP, Walter ND, Kenzie M. Seasonality of Tuberculosis in the United States, 1993-2008. Clin Infect Dis 2012; 54: 1553–60. doi: 10.1093/cid/cis235
25
Akhtar S, Mohammad HG. Seasonality in pulmonary tuberculosis among migrant workers entering Kuwait. BMC Infect Dis 2008; 8: 3. doi: 10.1186/1471-2334-8-3
26
Metanat M, Sharifi-Mood B, Alavi-Naini R, Aminianfar M. [The epidemiology of tuberculosis in recent years: Reviewing the status in south-eastern Iran]. Zahedan J Res Med Sci 2012; 13: 1–7.
27
Nasehi M, Mohammad K, Gouya MM, Madjdzadeh SR, Zamani G, Holakoii K, et al. Health Care System Delay in Diagnosis and Treatment of Contagious Tuberculosis in I.R. IRAN – 2003. Tanaffos 2003; 2: 55–64.
28
Taghizadeh Asl R, Mohammad K, Majdzadeh R. [Seasonality pattern of Tuberculosis in Iran]. Journal of School of Public Health 2012; 3. Available from: http://cdn.medlib.ir/oldPDF/58/1639/17144.pdf
29
ORIGINAL_ARTICLE
The Financial Cost of Preventive and Curative Programs for Breast Cancer: A Case Study of Women in Shiraz-Iran
Background This cross-sectional study was conducted to compare the average costs of breast cancer screening and treatment among women with the age of 25 and over in Shiraz-Iran. Methods Three majors hospitals affiliated with Shiraz University of Medical Sciences (SUMS) were selected for data collection. Financial documents and interviews with the hospitals’ financial officers were used for data collection. Results Finding shows that the total cost of screening would be 5,847,544.96 US dollars for age groups of 25–34 and 35 and above, demonstrating the huge expense of screening programs. On the other hand, the average cost of breast cancer treatment for each patient would be 3608.47, 996.89, and 311.47 US dollars for mastectomy, radiotherapy, and chemotherapy, respectively. In addition, the total average cost for treatment of 2217 patients would be 1,466,988.9 US dollars, which is much less than screening programs expenses. Conclusion It is concluded that although screening can be effective for improving quality of life and treatment effectiveness, considering the high costs of screening, it is not economical in Iran. Screening methods within suitable intervals, and also considering patients’ medical history have been recommended by the present study.
https://www.ijhpm.com/article_2841_a5c9c4771dc4c2899b897d33c42efafe.pdf
2014-05-01
187
191
10.15171/ijhpm.2014.44
Breast Cancer
Screening
Treatment
Cost-Effectiveness
Nahid
Hatam
hatamn@sums.ac.ir
1
School of Health Administration and Medical Information, Shiraz University of Medical Sciences, Shiraz, Iran
AUTHOR
Vahid
Keshtkar
keshtkarv@sums.ac.ir
2
Department of Community Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
AUTHOR
Asiyeh
Salehi
nasim.salehi@griffithuni.edu.au
3
Griffith Health Institute, Griffith University, QLD, Australia
LEAD_AUTHOR
Hamidreza
Rafei
4
School of Health Administration and Medical Information, Shiraz University of Medical Sciences, Shiraz, Iran
AUTHOR
Micheli A, Coebergh JW, Mugno E, Massimiliani E, Sant M, Oberaigner W, et al. European heath systems and cancer care. Ann Oncol 2003; 14: 41–60.
1
Mohaghegh FA, Hamta A, Shariat Zade SA. [Investigation of current cancers in Markazi province and its registration system in 2001-2006 in compare with country statistics]. Journal of Arak University of Medical Sciences 2008; 11: 84–94.
2
Akbari ME, Naghavi M. [Economical burden of cancers in Iran]. Daroo and darman Journal 2009; 67: 51–6.
3
Hatam N, Ahmadloo N, Ahmad Kia Daliri A, Bastani P, Askarian M. Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil). Arch Gynecol Obstet 2011; 284: 215–20. doi: 10.1007/s00404-010-1609-8
4
Yen JY, Ko CH, Yen CF, Yang MJ, Wu CY, Juan CH, et al. Quality of life, depression, and stress in breast cancer women outpatients receiving active therapy in Taiwan. Psychiatry Clin Neurosci 2006; 60: 147–53. doi: 10.1111/j.1440-1819.2006.01479.x
5
Bland KI, Sarr MG, Buchler MW, Csendes A, Garden OJ, Wong J. General Surgery: Principles and International Practice. Australia: Springer; 2010.
6
Phipps WJ, Long BC, Woods N. Medical-surgical nursing: concepts and clinical practice. 5th ed. St. Louis, MO: Mosby; 1995.
7
Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi AM, Harirchi I, Najafi M, et al. Breast Cancer in Iran: an epidemiological review. Breast J 2007; 13; 383–91. doi: 10.1111/j.1524-4741.2007.00446.x
8
Gholikhani R, Sadrmomtaz N. [Health cost analysis]. 1st ed. Tehran: Debizesh publication; 2001.
9
Nouroozi T, Salehi A. Prime costs of clinical laboratory services in Tehran Valiasr Hospital in 2009. EMHJ 2013; 19: 159–65.
10
Hatam N, Bastani P, Ahmadloo N, Kiadaliri AA. Health Related Quality of Life in Breast Cancer Patients Undergoing Current Chemotherapy Protocols. Kerman University of Medical Sciences Journal 2011; 19: 37–46.
11
Phipps WJ, Long BC, Woods N. Medical-surgical nursing. 7th ed. St. Louis, MO: Mosby; 2003.
12
Andersen R, Hager M. Analysis of the cost-effectiveness of mammography promotion by volunteers in rural communities. Health Educ Behav 2002; 29: 755-70. doi: 10.1177/109019802237942
13
Zwahlen M, Probst N, Baschung B, de Wolf C, Marty-Tschumi E, Borisch B. Early detection of breast cancer using mammography-a position paper of the Swiss Cancer League [internet]. 2003. Swiss Cancer League. Available from: http://assets.krebsliga.ch/downloads/pospap_final_kls_en_.pdf
14
Risenquist J, Lindfors K. Screening mammography in women aged 40-49 years: analysis if cost-effectiveness. Radiology 1994; 191: 647–50.
15
Lebovic GS, Hollingsworth A, Feig SA. Risk assessment, screening and prevention of breast cancer: A look at cost-effectiveness. Breast 2010; 19: 260–7. doi: 10.1016/j.breast.2010.03.013
16
Pisati G, Cerri S, Marinelli M, Tedeschi B, Valsecchi E. [Cancer screening programme in health care workers]. G Ital Med Lav Ergon 2011; 33: 57–60.
17
Hadi N, Sadeghi-Hassanabadi A, Talei AR, Arasteh MM, Kazerooni T. Assessment of a breast cancer screening programme in Shiraz, Islamic Republic of Iran. East Mediterr Health J 2002; 8: 386–92.
18
Grann VR, Patel PR, Jacobson JS, Warner E, Heitjan DF, Ashby-Thompson M, et al. Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers. Breast Cancer Res Treat 2011; 125: 837–47. doi: 10.1007/s10549-010-1043-4
19
Smith RA. Cancer screening in the USA. J Med Screen 2006; 13: 48–53.
20
Mehrabani D, Tabei SZ, Heydari ST, Shamsina SJ, Shokrpour N, Amini M, et al. Cancer Occurrence in Fars Province, Southern Iran. Iran Red Crescent Med J 2008; 10: 314–22.
21
Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med 2011; 155: 10–20. doi: 10.7326/0003-4819-155-1-201107050-00003
22
Boer R, de Koning H, Threlfall A, Warmerdam P, Street A, Friedman E, et al. Cost effectiveness of shortening screening interval in extending age range of NHS breast screening programme: computer simulation study. BMJ 1998; 317: 376-9. doi: 10.1136/bmj.317.7155.376
23
Stout NK, Rosenberg MA, Trentham-Dietz A, Smith MA, Robinson SM, Fryback DG. Retrospective cost-effectiveness analysis of screening mammography. J Natl Cancer Inst 2006; 98: 774–82. doi: 10.1093/jnci/djj210
24
Peregrino AA, Vianna CM, de Almeida CE, Gonzáles GB, Machado SC, Costa e Silva FV, et al. [Analysis of Cost-effectiveness of screening for breast cancer with conventional mammography, digital and magnetic resonance imaging]. Cien Saude Colet 2012; 17: 215–22.
25
Verbeek AL, van Dijck JA, Kiemeney LA, Broeders MJ. Responsible cancer screening. Ned Tijdschr Geneeskd 2011; 155: A3934.
26
ORIGINAL_ARTICLE
Improving Immunization Rates of Underserved Children: A Historical Study of 10 Health Departments
Background Despite high immunization rates, hundreds of thousands of poor and underserved children continue to lack their necessary immunizations and are at risk of acquiring a vaccine-preventable disease. Local Health Departments (LHDs) and public health clinicians figure prominently in efforts to address this problem. Methods This exploratory research compared ten (10) North Carolina LHDs with respect to immunization delivery factors. The study sample was identified based on urban designation as well as county demographic and socio-economic indicators that identified predicted “pockets” of underimmunization. Survey instruments were used to identify specific LHD immunization delivery factors. Results It was found that hours of operation, appointment policies, use and type of tracking systems, and wait times influence a health department’s ability to immunize underserved children. This exploratory research is of particular importance, because it suggests that the implementation of specific policy interventions may reduce the morbidity and mortality related to vaccine-preventable diseases in poor and underserved children. This research also highlights the significance of the nurses’ role in the policy making process in this important area of community health assurance. Conclusion To improve childhood immunization rates, policy-makers should encourage adequate and appropriate funding for LHDs to adopt service delivery factors that are associated with higher-performing local health departments. LHDs should study the population they serve to further refine service delivery factors to meet the population’s needs.
https://www.ijhpm.com/article_2843_8f768301e5c0dcc9d9b29d70cb2660ed.pdf
2014-05-01
193
197
10.15171/ijhpm.2014.46
Health Status
Immunizations
Public Health Department
Children
Uninsured
Donald
Haley
rhaley@unf.edu
1
Health Administration Programs, Public Health Department, Brooks College of Health, University of North Florida, Florida, USA
LEAD_AUTHOR
ORIGINAL_ARTICLE
Toward More Compassionate Healthcare Systems; Comment on “Enabling Compassionate Healthcare: Perils, Prospects and Perspectives”
Compassion is central to the purpose of medicine and the care of patients and their families. Compassionate healthcare begins with compassionate people, but cannot be consistently provided without systemic changes that enable clinicians and staff to collaborate and to care. We propose seven essential commitments to foster more compassionate healthcare organizations and systems: a commitment to compassionate leadership, to teach compassion, to value and reward compassionate care, to support clinical caregivers, to involve and partner with patients and families, to build compassion into the organization of healthcare delivery, and a commitment to deepen our understanding of compassion and its impact through research. Acting on these commitments will help us attend with care to the ill, injured, and vulnerable in every interaction.
https://www.ijhpm.com/article_2838_eb9385eac7b3fbf76eb6065928088d1d.pdf
2014-05-01
199
200
10.15171/ijhpm.2014.41
Compassion
Healthcare Quality
Professional-Patient Relations
Beth
Lown
blown@mah.harvard.edu
1
The Schwartz Center for Compassionate Healthcare, Boston, MA, USA
LEAD_AUTHOR
Tipping MD, Forth VE, O’Leary KJ, Malkenson DM, Magill DB, Englert K, et al. Where did the day go?--a time-motion study of hospitalists. J Hosp Med 2010; 5: 323–8. doi: 10.1002/jhm.790
1
Linzer M, Manwell LB, Williams ES. Bobula JA, Brown RL, Varkey AB, Man B, et al. Working conditions in primary care: physician reactions and care quality. Ann Intern Med 2009; 151: 28–36.
2
Wallace JE, Lemaire JB, Ghali WA. Physician Wellness: a missing quality indicator. Lancet 2009; 374: 1714–21. doi: 10.1016/s0140-6736(09)61424-0
3
Mannion R. Enabling compassionate healthcare: perils, prospects and perspectives. Int J Health Policy Manag 2014; 2: 115-7. doi: 10.15171/ijhpm.2014.34
4
Weng HY, Fox AS, Shackman AJ, Stodola DE, Caldwell JZK, Olson MC, et al. Compassion training alters altruism and neural responses to suffering. Psychol Sci 2013; 24: 1171–80. doi: 10.1177/0956797612469537
5
Lown BA, Manning CF. The Schwartz Center Rounds: evaluation of an interdisciplinary approach to enhance patient-centered communication, teamwork and provider support. Acad Med 2010; 85: 1073–81. doi: 10.1097/acm.0b013e3181dbf741
6
ORIGINAL_ARTICLE
Sharpening the Health Policy Analytical Rapier; Comment on “The Politics and Analytics of Health Policy”
This commentary on the Editorial ‘The politics and analytics of health policy’ by Professor Calum Paton focuses on two issues. First, it points to the unclear links between ideas, ideology, values, and discourse and policy, and warns that discourse is often a poor guide to enacted policy. Second, it suggests that realism, particularly ‘programme theory’ are useful tools for health policy analysis. ‘Market reform’ cannot be reduced to a simple ‘four legs good, two legs bad’ verdict, and programme theory might suggest that certain mechanisms may be good for one outcome in a particular context, but bad for another.
https://www.ijhpm.com/article_2839_d6fed134fc1b5ea872ae7e7a2d3a6dab.pdf
2014-05-01
201
202
10.15171/ijhpm.2014.42
Health Policy
British National Health Service (NHS)
Discourse
Realism
Martin
Powell
m.powell@bham.ac.uk
1
Health Services Management Centre, School of Social Policy, The University of Birmingham, Birmingham, UK
LEAD_AUTHOR
Paton CR. The politics and analytics of health policy. Int J Health Policy Manag 2014; 2: 105–7. doi: 10.15171/ijhpm.2014.26
1
Powell M, Miller R. Privatizing the English National Health Service: An Irregular Verb? J Health Polit Policy Law 2013; 38: 1053–61. doi: 10.1215/03616878-2334918
2
Powell M. Making markets in the English National Health Service.Soc Policy Adm 2014; forthcoming.
3
Pawson R, Tilley N. Realistic Evaluation. London: Sage; 1997. doi: 10.1177/001789699905800111
4
Gingrich J. Making Markets in the Welfare State. Cambridge: Cambridge University Press; 2011. doi: 10.1017/s1537592713000601
5
ORIGINAL_ARTICLE
Ingredients for Good Health Policy-Making: Incorporating Power and Politics into the Mix
https://www.ijhpm.com/article_2842_47994110c904ba24c33d58ac43012ad5.pdf
2014-05-01
203
204
10.15171/ijhpm.2014.45
Health Policy
Power
Politics
Policy Analysis
Policy Theory
Yusra
Shawar
yusra.shawar@jhu.edu
1
Department of Public Administration and Public Policy, American University, Washington, USA
LEAD_AUTHOR